Man Group’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTK
VPM
VCM
ACA
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $690K | Sell |
10,463
-1,124
| -10% | -$71.4K | ﹤0.01% | 1967 |
|
|
2025
Q4 | $736K | Buy |
+11,587
| New | +$721K | ﹤0.01% | 1775 |
|
|
2025
Q1 | – | Sell |
-63,696
| Closed | -$3M | – | 2213 |
|
|
2024
Q4 | $3M | Sell |
63,696
-238,517
| -79% | -$12.4M | 0.01% | 1193 |
|
|
2024
Q3 | $16M | Buy |
302,213
+227,074
| +302% | +$12.7M | 0.05% | 531 |
|
|
2024
Q2 | $4.07M | Sell |
75,139
-7,505
| -9% | -$453K | 0.01% | 1094 |
|
|
2024
Q1 | $5.79M | Buy |
82,644
+74,357
| +897% | +$5.75M | 0.02% | 943 |
|
|
2023
Q4 | $692K | Buy |
+8,287
| New | +$300K | ﹤0.01% | 1567 |
|
|
2023
Q3 | – | Sell |
-244,107
| Closed | -$8.13M | – | 1644 |
|
|
2023
Q2 | $7.96M | Buy |
+244,107
| New | +$9.03M | 0.02% | 706 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 913 |
|
|
2022
Q3 | – | Hold |
0
| – | -$3.4M | – | 2062 |
|
|
2022
Q2 | – | Sell |
-52,653
| Closed | -$2.12M | – | 939 |
|
|
2022
Q1 | $1.94M | Buy |
+52,653
| New | +$1.87M | 0.01% | 1221 |
|
|
2019
Q1 | – | Sell |
-11,100
| Closed | -$70K | – | 1975 |
|
|
2018
Q4 | $70K | Sell |
11,100
-2,300
| -17% | -$16.9K | ﹤0.01% | 1869 |
|
|
2018
Q3 | $132K | Sell |
13,400
-4,900
| -27% | -$39.3K | ﹤0.01% | 2045 |
|
|
2018
Q2 | $152K | Sell |
18,300
-34,200
| -65% | -$285K | ﹤0.01% | 2047 |
|
|
2018
Q1 | $378K | Buy |
+52,500
| New | +$450K | ﹤0.01% | 1778 |
|